Class information for:
Level 1: TELAPREVIR//RIBAVIRIN//BOCEPREVIR

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
182 3943 37.0 84%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
37 32459 HEPATITIS C VIRUS//HEPATITIS C//HCV

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TELAPREVIR Author keyword 270 71% 6% 218
2 RIBAVIRIN Author keyword 229 29% 17% 655
3 BOCEPREVIR Author keyword 137 65% 3% 132
4 IL28B Author keyword 136 64% 3% 133
5 SUSTAINED VIROLOGICAL RESPONSE Author keyword 122 52% 4% 169
6 PEGYLATED INTERFERON Author keyword 113 38% 6% 237
7 SIMEPREVIR Author keyword 91 83% 1% 52
8 PEGINTERFERON Author keyword 85 50% 3% 123
9 CHRONIC HEPATITIS C Author keyword 82 18% 10% 403
10 DIRECT ACTING ANTIVIRAL Author keyword 81 79% 1% 52

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 TELAPREVIR 270 71% 6% 218 Search TELAPREVIR Search TELAPREVIR
2 RIBAVIRIN 229 29% 17% 655 Search RIBAVIRIN Search RIBAVIRIN
3 BOCEPREVIR 137 65% 3% 132 Search BOCEPREVIR Search BOCEPREVIR
4 IL28B 136 64% 3% 133 Search IL28B Search IL28B
5 SUSTAINED VIROLOGICAL RESPONSE 122 52% 4% 169 Search SUSTAINED+VIROLOGICAL+RESPONSE Search SUSTAINED+VIROLOGICAL+RESPONSE
6 PEGYLATED INTERFERON 113 38% 6% 237 Search PEGYLATED+INTERFERON Search PEGYLATED+INTERFERON
7 SIMEPREVIR 91 83% 1% 52 Search SIMEPREVIR Search SIMEPREVIR
8 PEGINTERFERON 85 50% 3% 123 Search PEGINTERFERON Search PEGINTERFERON
9 CHRONIC HEPATITIS C 82 18% 10% 403 Search CHRONIC+HEPATITIS+C Search CHRONIC+HEPATITIS+C
10 DIRECT ACTING ANTIVIRAL 81 79% 1% 52 Search DIRECT+ACTING+ANTIVIRAL Search DIRECT+ACTING+ANTIVIRAL

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 GENOTYPE 1 INFECTION 492 60% 13% 532
2 TELAPREVIR 467 65% 11% 446
3 SUSTAINED VIROLOGICAL RESPONSE 421 50% 15% 603
4 PLUS RIBAVIRIN 408 35% 24% 949
5 PEGINTERFERON ALPHA 2A 316 39% 16% 632
6 PEGINTERFERON ALPHA 2B 299 56% 9% 366
7 BOCEPREVIR 267 64% 7% 263
8 PEGINTERFERON 267 50% 10% 387
9 PEGYLATED INTERFERON 219 42% 10% 402
10 ALPHA 2B PLUS RIBAVIRIN 210 55% 7% 265

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 JOURNAL OF VIRAL HEPATITIS 25 11% 6% 222

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges 2014 86 56 59%
HCV direct-acting antiviral agents: the best interferon-free combinations 2014 58 24 71%
Current and Future Therapies for Hepatitis C Virus Infection 2013 117 59 61%
Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection 2014 33 10 100%
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies 2013 95 51 65%
Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care 2012 65 46 83%
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence 2013 192 25 28%
Treatment of Hepatitis C A Systematic Review 2014 37 49 73%
Perspectives and challenges of interferon-free therapy for chronic hepatitis C 2013 54 43 81%
New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives 2012 83 41 59%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TEXAS LIVER 50 75% 0.9% 36
2 LIVER VIRGINIA 45 83% 0.6% 25
3 REFERENCE VIRAL HEPATITIS B C D 18 89% 0.2% 8
4 EA 4294 15 82% 0.2% 9
5 LIVER PROJECT 13 36% 0.7% 29
6 HEPATOL SECT 11 22% 1.1% 44
7 NIHR BIOMED UNIT GASTROENTEROL LIVER 9 83% 0.1% 5
8 AM MIGLIAVACCA LIVER DIS 8 52% 0.3% 11
9 HOSP UNIV NANCY 8 34% 0.5% 19
10 HEPATITIS IMMUNOL 7 19% 0.9% 34

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000223541 IFN LAMBDA//IL 29//INTERLEUKIN 29
2 0.0000208111 CHRONIC HEPATITIS C//INTERFERON THERAPY//HCV RNA
3 0.0000156919 INJECTING DRUG USE//HEPATITIS C TREATMENT//VIRAL HEPATITIS CLIN PROGRAM
4 0.0000137278 NS5B POLYMERASE//HCV NS5B POLYMERASE//NS3 PROTEASE
5 0.0000130681 HCV GENOTYPES//INTERFERON SENSITIVITY DETERMINING REGION//HYPERVARIABLE REGION 1
6 0.0000130407 MN II CATALYSED//RIBAVIRIN TRIPHOSPHATE//M ANISIDINE
7 0.0000124973 HIV HCV CO INFECTION//HIV HCV COINFECTION//COINFECTION
8 0.0000107339 HCV CORE ANTIGEN//HCV CORE ANTIGEN ASSAY//HCV RNA STABILITY
9 0.0000106349 STEATOSIS//HEPATOGENOUS DIABETES//DIPARTIMENTO MED GASTROENTEROL ALMA MATER STUDI
10 0.0000102235 JENS//BEHAV HLTH CLIN NEUROSCI//NW HEPATITIS OURCE C